版权说明 帮助中心
首页 > 成果 > 详情

美沙拉嗪肠溶缓释微丸的制备及体外释放度考察

认领
导出
Link by 中国知网学术期刊 Link by 维普学术期刊 Link by 万方学术期刊
反馈
分享
QQ微信 微博
成果类型:
期刊论文
论文标题(英文):
Study on the preparation and in vitro dissolution of mesalamine extended-release enteric pellets
作者:
苏诗娜[1,2,3];吕竹芬[1,2];梁超峰;卢克伟;陈燕忠[1,2]
作者机构:
[陈燕忠[1,2]] 陈燕忠
[吕竹芬[1,2]] 吕竹芬
[梁超峰] 梁超峰
[卢克伟] 卢克伟
[苏诗娜[1,2,3]] 苏诗娜
语种:
中文
关键词:
美沙拉嗪;肠溶缓释微丸;体外释放度;尤特奇(R) NE30D
关键词(英文):
mesalamine;extended-release enteric pellets;in vitro dissolution behavior;Eudragit NE30D
期刊:
广东药科大学学报
期刊(英文):
Journal of Guangdong Pharmaceutical University
ISSN:
2096-3653
年:
2018
卷:
34
期:
2
页码:
127-131,136
基金类别:
广州市科技计划项目(201508010050); 2015广东省普通高校创新团队建设项目(2015KCXTD026); 2015广东省普通高校特色创新类项目(2015KTSCX075);
机构署名:
本校为其他机构
院系归属:
药学院
摘要:
目的 制备美沙拉嗪肠溶缓释微丸,并考察其体外溶出行为.方法 采用微晶纤维素、羟丙甲纤维素(HPMC)K4M和尤特奇(R) NE30D制备缓释骨架丸芯,以尤特奇(R) S100和L100为肠溶材料包衣,制备美沙拉嗪肠溶缓释微丸.采用单因素试验,以释放度和相似因子f2为指标筛选处方中尤特奇(R) NE30D用量、HPMC型号和用量、丸芯干燥条件、包衣材料用量及包衣增重.结果 丸芯最优处方为美沙拉嗪213.15 g、微晶纤维素52.50 g、HPMC K4M 7.00 g和尤特奇(R)NE30D 221.67 g,包衣处方中尤特奇(R) S100和L100比例为2∶3(质量比),最佳包衣增重为14%.自制制剂和原研制剂在pH6.8磷酸盐缓冲液的体外释放行为相似.结论 成功制得美沙拉嗪肠溶缓释微丸,其体外溶出行为与原研制剂相似.
摘要(英文):
Objective To prepare mesalamine extended-release enteric pellets and study its in vitro dissolution.Methods Microcrystalline cellulose(MCC),hypromellose K4M(HPMC K4M)and Eudragit NE30D were used to prepare the extended-release matrix core.Mesalamine extended-release enteric pellets were prepared by using Eudragit S100 and L100 as enteric coating material.Single factor test was used to screen the amount of Eudragit NE30D,the amount of Eudragit S100 and L100,amount of HPMC and weight of coating layer in the formulation by using dissolution rate and the similar factor f 2 as indexes.Results The optimal formulation of mesalamine extended-release matrix core was as follows:Mesalamine 213.15 g,MCC 52.50 g,HPMC K4M 7.00 g,Eudragit NE30D 221.67 g,the ratio of Eudragit S100 and L100 was 2∶3 and the optimum coating weight gain was 14%.The in vitro release of self-made and original preparations was similar in pH6.8 phosphate buffer.Conclusion Mesalamine extended-release enteric pellets have been prepared successfully,and its in vitro dissolution behavior is similar to the original preparations.

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com